BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29507391)

  • 1. Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
    Gechijian LN; Buckley DL; Lawlor MA; Reyes JM; Paulk J; Ott CJ; Winter GE; Erb MA; Scott TG; Xu M; Seo HS; Dhe-Paganon S; Kwiatkowski NP; Perry JA; Qi J; Gray NS; Bradner JE
    Nat Chem Biol; 2018 Apr; 14(4):405-412. PubMed ID: 29507391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network.
    Liu J; Li F; Bao H; Jiang Y; Zhang S; Ma R; Gao J; Wu J; Ruan K
    FEBS J; 2017 Apr; 284(7):1082-1095. PubMed ID: 28207202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
    Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
    J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
    Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
    Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.
    Appikonda S; Thakkar KN; Shah PK; Dent SYR; Andersen JN; Barton MC
    J Biol Chem; 2018 May; 293(19):7476-7485. PubMed ID: 29523690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
    Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
    J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM24 links a non-canonical histone signature to breast cancer.
    Tsai WW; Wang Z; Yiu TT; Akdemir KC; Xia W; Winter S; Tsai CY; Shi X; Schwarzer D; Plunkett W; Aronow B; Gozani O; Fischle W; Hung MC; Patel DJ; Barton MC
    Nature; 2010 Dec; 468(7326):927-32. PubMed ID: 21164480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
    Groner AC; Cato L; de Tribolet-Hardy J; Bernasocchi T; Janouskova H; Melchers D; Houtman R; Cato ACB; Tschopp P; Gu L; Corsinotti A; Zhong Q; Fankhauser C; Fritz C; Poyet C; Wagner U; Guo T; Aebersold R; Garraway LA; Wild PJ; Theurillat JP; Brown M
    Cancer Cell; 2016 Jun; 29(6):846-858. PubMed ID: 27238081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
    Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
    Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gene expression in human cancers by TRIM24.
    Appikonda S; Thakkar KN; Barton MC
    Drug Discov Today Technol; 2016 Mar; 19():57-63. PubMed ID: 27769359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
    Fong KW; Zhao JC; Song B; Zheng B; Yu J
    Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
    Vangamudi B; Paul TA; Shah PK; Kost-Alimova M; Nottebaum L; Shi X; Zhan Y; Leo E; Mahadeshwar HS; Protopopov A; Futreal A; Tieu TN; Peoples M; Heffernan TP; Marszalek JR; Toniatti C; Petrocchi A; Verhelle D; Owen DR; Draetta G; Jones P; Palmer WS; Sharma S; Andersen JN
    Cancer Res; 2015 Sep; 75(18):3865-3878. PubMed ID: 26139243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
    Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
    Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains.
    Palmer WS
    Drug Discov Today Technol; 2016 Mar; 19():65-71. PubMed ID: 27769360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer.
    Höflmayer D; Fraune C; Hube-Magg C; Simon R; Schroeder C; Büscheck F; Möller K; Dum D; Weidemann S; Wittmer C; Schlomm T; Huland H; Heinzer H; Graefen M; Haese A; Sauter G; Burandt E; Clauditz TS; Steurer S; Minner S; Wilczak W; Polonski A
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):e29-e38. PubMed ID: 33491944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.
    Pathiraja TN; Thakkar KN; Jiang S; Stratton S; Liu Z; Gagea M; Shi X; Shah PK; Phan L; Lee MH; Andersen J; Stampfer M; Barton MC
    Oncogene; 2015 May; 34(22):2836-45. PubMed ID: 25065590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dTAG system for immediate and target-specific protein degradation.
    Nabet B; Roberts JM; Buckley DL; Paulk J; Dastjerdi S; Yang A; Leggett AL; Erb MA; Lawlor MA; Souza A; Scott TG; Vittori S; Perry JA; Qi J; Winter GE; Wong KK; Gray NS; Bradner JE
    Nat Chem Biol; 2018 May; 14(5):431-441. PubMed ID: 29581585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
    Zhan Y; Kost-Alimova M; Shi X; Leo E; Bardenhagen JP; Shepard HE; Appikonda S; Vangamudi B; Zhao S; Tieu TN; Jiang S; Heffernan TP; Marszalek JR; Toniatti C; Draetta G; Tyler J; Barton M; Jones P; Palmer WS; Geck Do MK; Andersen JN
    Epigenetics Chromatin; 2015; 8():37. PubMed ID: 26396593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.
    Fang Z; Zhang L; Liao Q; Wang Y; Yu F; Feng M; Xiang X; Xiong J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):17. PubMed ID: 28114950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of novel N-benzyl-3,6-dimethylbenzo[d]isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities.
    Hu Q; Wang C; Xiang Q; Wang R; Zhang C; Zhang M; Xue X; Luo G; Liu X; Wu X; Zhang Y; Wu D; Xu Y
    Bioorg Chem; 2020 Jan; 94():103424. PubMed ID: 31776034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.